Form 8-K - Current report:
SEC Accession No. 0000950134-05-006286
Filing Date
2005-03-30
Accepted
2005-03-30 06:01:21
Documents
3
Period of Report
2005-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c93671e8vk.htm 8-K 11211
2 PRESS RELEASE c93671exv99w1.htm EX-99.1 13430
3 GRAPHIC c93671biosantelogo.gif GRAPHIC 10899
  Complete submission text file 0000950134-05-006286.txt   37499
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 05711447
SIC: 2836 Biological Products, (No Diagnostic Substances)